U.S. Stock News

NYSE:VYX
NYSE:VYXSoftware

Is NCR Voyix (VYX) Now Attractive After Recent Share Price Rebound?

Wondering whether NCR Voyix at US$8.09 is starting to look cheap, or still carries too much risk for the price you pay? The stock has moved sharply in the short term, with a 17.4% return over 7 days and 29.2% over 30 days, although returns are negative at 18.0% year to date and 20.4% over 1 year. These recent moves sit against a longer track record that includes 42.7% and 71.8% returns over 3 and 5 years respectively. These figures may reflect shifting sentiment and changing expectations for...
NYSE:ESE
NYSE:ESEMachinery

Assessing ESCO Technologies (ESE) Valuation After Strong Multi Year Returns And Recent Share Price Momentum

Key business profile and recent share performance ESCO Technologies (ESE) has drawn fresh attention after its recent share move, with the stock last closing at $332.77 and showing positive returns over the past week, month and past 3 months. For investors tracking longer horizons, ESCO Technologies has also recorded positive total returns year to date, over the past year, and across the past 3 and 5 years. This context helps frame the current valuation conversation. See our latest analysis...
NYSE:DOLE
NYSE:DOLEFood

How Shipping Pressures and Theme Park Treats Will Impact Dole (DOLE) Investors

Dole plc recently prepared to report its first-quarter results amid rising shipping costs, softer European demand tied to the Iran conflict, and currency pressures, raising concerns about already thin margins. At the same time, Disney Springs’ Swirls on the Water introduced a new DOLE Whip Flight, underscoring the enduring consumer appeal of Dole-branded treats in experiential leisure settings. We’ll now explore how expectations around Dole’s earnings resilience under higher shipping costs...
NYSE:ZBH
NYSE:ZBHMedical Equipment

Reaffirmed Guidance and CFO Exit Might Change The Case For Investing In Zimmer Biomet (ZBH)

Zimmer Biomet Holdings reported past first-quarter 2026 results with sales of US$2,086.7 million and net income of US$238.1 million, reaffirming its full-year revenue guidance. Alongside continued share repurchases, the company announced the departure of its CFO and appointed its Controller and Chief Accounting Officer as interim CFO, raising questions about leadership continuity in its finance function. Next, we’ll examine how reaffirmed guidance alongside the CFO transition may influence...
NasdaqGS:AAPL
NasdaqGS:AAPLTech

Assessing Whether Apple (AAPL) Looks Overvalued As Recent Returns Extend Multi Year Momentum

Apple’s recent performance and scale Apple (AAPL) is drawing investor attention as its stock recently closed at $293.32, with returns of 2% over the past day, 4.7% over the past week, and 12.6% over the past month. Over the past 3 months, the stock shows a 6.8% return, while the 1 year total return stands at 48.4%. Longer term, Apple’s 3 year and 5 year total returns are 72.2% and 135.9% respectively, illustrating sizeable compounding over time. The company operates at a large scale,...
NYSE:FOUR
NYSE:FOURDiversified Financial

A Look At Shift4 Payments (FOUR) Valuation After Q1 2026 Beat And New Sports Venue Deals

Shift4 Payments (FOUR) is back in focus after its first quarter 2026 earnings, reporting revenue of US$1.12b and net income of US$15 million, along with new high profile sports venue partnerships. See our latest analysis for Shift4 Payments. The stock reacted sharply to the Q1 2026 update, with a 1-day share price return of 9.26% and a 30-day share price return of 16.34%. However, the year-to-date share price return of 25.26% and 1-year total shareholder return of 45.16% both remain weak,...
NYSE:MO
NYSE:MOTobacco

Is Altria Group (MO) Still Attractive After Strong Multi Year Share Price Gains

If you are wondering whether Altria Group stock still offers value at around US$69.04, it helps to start by lining up its price against what the fundamentals suggest. The stock has seen a 5.0% decline over the last 7 days, while returns sit at 4.2% over 30 days, 20.5% year to date and 22.3% over 1 year, with very large gains over 3 and 5 years of 91.1% and 103.3% respectively, which can change how you think about both opportunity and risk. Recent coverage has focused on Altria Group's...
NasdaqGS:ICLR
NasdaqGS:ICLRLife Sciences

A Look At ICON (NasdaqGS:ICLR) Valuation After Recent Mixed Share Price Performance

ICON stock performance snapshot after recent moves ICON (ICLR) has caught investor attention after a recent share price move, with the stock closing at $125. Short term returns show mixed momentum, including a 0.7% gain over the past day. Over the past week and month, ICON has recorded returns of 5.6% and 16.6% respectively. Performance over the past 3 months and year to date reflects double digit declines, highlighting uneven sentiment around the stock. See our latest analysis for ICON. That...
NasdaqGS:INVA
NasdaqGS:INVAPharmaceuticals

What Innoviva (INVA)'s Profit Rebound and ESOP Share Filing Means For Shareholders

In early May 2026, Innoviva, Inc. reported first-quarter 2026 results, with revenue of US$97.99 million and net income of US$186.6 million, marking a clear turnaround from the prior year’s loss. Around the same time, Innoviva filed a US$207.99 million shelf registration for up to 9,000,000 common shares tied to its employee stock ownership plan, underscoring management’s focus on employee alignment alongside growth in its recurring royalty and Specialty Therapeutics businesses. We’ll now...
NYSE:GNW
NYSE:GNWInsurance

A Look At Genworth Financial (GNW) Valuation After Flat Q1 2026 Revenue And Lower Net Income

What Genworth’s latest quarter tells you about the stock Genworth Financial (GNW) put fresh numbers on the table with its first quarter 2026 report, pairing flat revenue and lower net income with stronger operating cash flow and active share repurchases. See our latest analysis for Genworth Financial. Genworth’s share price has held close to US$9.14 despite a 5.9% 1 month share price return and a 30.2% 1 year total shareholder return, which suggests that recent earnings softness and active...
NYSE:IEX
NYSE:IEXMachinery

Assessing IDEX (IEX) Valuation After Stronger Earnings Dividend Streak And Share Buybacks

Why IDEX (IEX) is back on investors’ radar IDEX (IEX) has drawn fresh attention after reporting first quarter 2026 results with higher sales and net income, declaring its 126th consecutive quarterly dividend and updating investors on completed share repurchases. See our latest analysis for IDEX. The earnings beat, long dividend record and fresh buyback activity come after a strong run, with a 30 day share price return of 12.01% and a 1 year total shareholder return of 18.18%, suggesting...
NYSE:PIPR
NYSE:PIPRCapital Markets

Assessing Piper Sandler (PIPR) Valuation After Higher Revenue And A 14% Dividend Increase

Piper Sandler Companies (PIPR) has put capital returns in focus after reporting first quarter 2026 results, pairing higher revenue with a 14% lift in its quarterly dividend and ongoing share repurchases. See our latest analysis for Piper Sandler Companies. Despite the recent earnings release, the stock has seen a 7.73% 7 day share price decline and an 8.04% year to date share price decline. However, the 1 year total shareholder return of 28.89% and very large 3 and 5 year total shareholder...
NYSE:ASAN
NYSE:ASANSoftware

Assessing Asana (ASAN) Valuation As Recent Returns Contrast With Long-Term Momentum

Setting the scene for Asana stock Asana (ASAN) has been on investors’ radar after recent trading, with the stock closing at $7.05. With mixed short and longer term returns, many are reassessing how its work management platform fits their portfolio. See our latest analysis for Asana. Recent trading has pushed Asana’s 7 day share price return to 11.55% and 30 day return to 13.71%. However, the year to date share price return of 45.60% and 1 year total shareholder return of 59.13% indicate that...
NasdaqCM:CPRX
NasdaqCM:CPRXBiotechs

A Look At Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Momentum

Why Catalyst Pharmaceuticals Stock Is On Investors’ Radar Catalyst Pharmaceuticals (CPRX) has drawn attention after a period of strong share-price moves, with returns over the past month, past 3 months and year all in positive territory according to recent performance data. For investors tracking US biopharmaceutical stocks focused on rare diseases, this kind of sustained positive return profile can prompt a closer look at how the current share price relates to earnings, profitability and...
NasdaqGS:SOFI
NasdaqGS:SOFIConsumer Finance

A Look At SoFi Technologies (SOFI) Valuation After Strong Q1 2026 Earnings And Membership Growth

SoFi Technologies (SOFI) has drawn fresh attention after reporting Q1 2026 earnings that included US$1.1b in net revenue, net income of US$166.7 million, and record loan and deposit balances. See our latest analysis for SoFi Technologies. Despite strong Q1 results, SoFi’s recent 1-day and 90-day share price returns of 1.84% and 23.3% declines contrast with a 1-year total shareholder return of 20.66% and a 3-year total shareholder return above 3x. This points to fading near term momentum but...
NYSE:DHR
NYSE:DHRLife Sciences

Assessing Danaher (DHR) Valuation As Shares Weaken And Undervaluation Debate Grows

Why Danaher Stock Is On Investors’ Radar Now Danaher (DHR) has drawn fresh attention after recent share price moves, with the stock showing a return of about 0.4% over the past day but weaker performance across the month and past 3 months. See our latest analysis for Danaher. At a share price of $175.66, Danaher's recent 30 day share price return of an 8.0% decline and year to date share price return of a 23.8% decline suggest momentum has been fading, despite a smaller 9.2% decline in the 1...
NasdaqGS:HWKN
NasdaqGS:HWKNChemicals

Evaluating Hawkins (HWKN) Valuation After Strong Recent Share Price Momentum

Why Hawkins (HWKN) Is On Investors’ Radar Recent trading in Hawkins (HWKN) has drawn attention after the stock’s recent month and past 3 months performance, prompting investors to reassess what the current price of $167.01 implies. With returns of 13.88% over the past month and 24.28% in the past 3 months, Hawkins’ recent move sits against a backdrop of longer term total returns and a business spanning water treatment, industrial chemicals, and health and nutrition ingredients. See our latest...
NasdaqGM:AUPH
NasdaqGM:AUPHBiotechs

A Look At Aurinia Pharmaceuticals (AUPH) Valuation After Strong Q1 2026 Earnings Beat

Aurinia Pharmaceuticals (AUPH) has drawn fresh attention after reporting first quarter 2026 results. Revenue was US$77.71 million and net income was US$34.36 million, both higher than the prior year period. See our latest analysis for Aurinia Pharmaceuticals. The earnings beat and reiterated 2026 guidance arrived alongside a 4.9% 90 day share price return and an 86.7% 1 year total shareholder return, suggesting strong recent momentum despite short term share price weakness. If Aurinia’s...
NYSE:CCK
NYSE:CCKPackaging

A Look At Crown Holdings (CCK) Valuation After Q1 Earnings And Dividend Confirmation

Earnings and dividend announcement set the tone for Crown Holdings stock Crown Holdings (CCK) recently reported first quarter 2026 results alongside an affirmation of its regular quarterly dividend, giving investors fresh information on both the company’s operating performance and its ongoing cash return policy. See our latest analysis for Crown Holdings. The recent earnings release, which showed quarterly sales of US$3,259 million and net income of US$175 million, together with the affirmed...
NYSE:BUR
NYSE:BURDiversified Financial

How Burford’s US$1.72 Billion YPF Charge and New Leaders Will Impact Burford Capital (BUR) Investors

In May 2026, Burford Capital reported a very large non-cash revenue loss of US$1.72 billion and a net loss of US$1.63 billion for the first quarter, primarily linked to a capital provision tied to the reversal of its YPF judgment, while also strengthening liquidity through new long-dated debt. At the same time, Burford reshaped its leadership bench by appointing Travis Lenkner as Chief Operating Officer and promoting Carrie Tendler to lead Asset Recovery, signaling a focus on execution,...
NasdaqGS:CMPR
NasdaqGS:CMPRCommercial Services

How Cimpress’ Swing to Q3 Profit and Stronger Margins At Cimpress (CMPR) Has Changed Its Investment Story

Cimpress plc has reported past third-quarter 2026 results showing sales of US$886.21 million versus US$789.47 million a year earlier, with net income of US$13.84 million compared with a net loss of US$8.24 million and basic earnings per share from continuing operations improving from US$0.33 loss to US$0.57. Over the first nine months to March 31, 2026, Cimpress lifted sales to US$2.79 billion and more than doubled net income to US$70.82 million, highlighting materially stronger...
NYSE:WD
NYSE:WDDiversified Financial

Why Walker & Dunlop (WD) Is Up 8.9% After Strong Q1 2026 Results And Dividend Affirmation

Walker & Dunlop, Inc. has reported past first-quarter 2026 results, with revenue rising to US$301.33 million and net income to US$15.87 million, alongside affirming a quarterly dividend of US$0.68 per share payable on June 4, 2026. Beneath these headline figures, the company highlighted very large growth in transaction volumes and agency lending, supported by complex refinancing deals and higher productivity per banker that helped increase its share of the GSE lending market. We’ll now...
NasdaqGS:MMYT
NasdaqGS:MMYTHospitality

Assessing MakeMyTrip (NasdaqGS:MMYT) Valuation After Recent Share Price Momentum

What recent returns say about MakeMyTrip stock MakeMyTrip (MMYT) has moved sharply in recent months, with a 2.1% gain over the past day, about 7% over the past week, and roughly 32% over the past month. See our latest analysis for MakeMyTrip. While the recent 32% 1 month share price return points to strong short term momentum, this comes after a 38.3% year to date share price decline and a 48% 1 year total shareholder return loss, set against much stronger 3 and 5 year total shareholder...
NYSE:AWI
NYSE:AWIBuilding

A Look At Armstrong World Industries (AWI) Valuation After Its First Quarter 2026 Earnings Update

Armstrong World Industries (AWI) has put investors on alert after its first quarter 2026 update, combining higher year-on-year sales, slightly lower net income and a reaffirmed full year net sales outlook. See our latest analysis for Armstrong World Industries. The reaffirmed 2026 net sales outlook and management's focus on M&A have come after a 16.7% decline in the 90 day share price return, even as the 3 year total shareholder return sits at 157.8%. This suggests long term momentum has been...